Skip to content
Lower risk Medical device recall · FDA · Published November 29, 2023

Randox RX Series Copper Assay: False High Copper Results Risk

Randox recalls RX Series Copper (Cu) Assay Ref. CU2340 due to risk of falsely elevated copper results when run after total protein tests. Affected units have specific batch numbers.

🇺🇸 FDA recall #Z-0992-2024Medical deviceRandox ›
Take action

Contact the company

Recalling firmRandox Laboratories Ltd.55 Diamond Road · Crumlin (North), Ireland
✎ GovInfoNow plain-language explainer

Randox is recalling RX Series Copper (Cu) Assay Ref. CU2340 because running this test after total protein tests can cause false high copper results. This affects laboratory users who test samples on these instruments. Read more at govinfonow.com/recall/56732-randox-rx-series-copper-assay-false-high-copper-results-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/56732-randox-rx-series-copper-assay-false-high-copper-results-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0992-2024

Cite this page

“Randox RX Series Copper Assay: False High Copper Results Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56732-randox-rx-series-copper-assay-false-high-copper-results-risk. Based on FDA recall #Z-0992-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0992-2024%22&limit=1).

The FDA announced on 2023-11-29 that Randox Laboratories Ltd. is recalling RX Series Copper (Cu) Assay Ref. Number CU2340 due to the risk of falsely elevated copper results. The agency stated that running the assay directly after Total Protein can cause this error.

How to tell if you have it

  • Brand: Randox
  • Product: RX Series Copper (Cu) Assay
  • Ref. Number: CU2340
  • Catalogue Number/GTIN: CU2340 05055273201949
  • Lot codes: 592278, 610661, 610669, 629021, 647201, 657944
  • Quantity: 3,053 kits (2 US, 3,051 OUS)
  • Distribution: SC and OK

The hazard

Randox Laboratories released an update to the Carryover Avoidance Technical Bulletin detailing that Copper should not be run directly after Total Protein on RX series instruments. If the copper assay is run after total protein, it could lead to falsely elevated copper results.

Context

GovInfoNow's records show Randox Laboratories Ltd. has 49 other recalls on record since 2017-06-07. Other recent recalls of similar products include Randox Cystatin C Reagent Recall (2024-06-07), Randox Evidence MultiSTAT Software v3.7 Recall (2024-04-05), and Randox Clinical Chemistry Calibration Serum Recall (2024-03-05). Siemens Atellica CH RCRP Test May Give False High Results was recalled on 2026-08-17.

How to tell if you have this one

Check for the product name 'RX Series Copper (Cu) Assay Ref. Number CU2340' with batch numbers 592278, 610661, 610669, 629021, 647201, or 657944.

  • Brand
    Randox
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify if your Copper assay has the batch numbers listed in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 2 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution in the states of SC and OK.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Oklahoma, South Carolina.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Nov 29, 202312. FDA classified it Class II: Feb 6, 202423. Published in FDA’s Enforcement Report: Feb 14, 2024320232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0992-2024 (November 29, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0992-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA